Icon Plc
ICLRICON plc (ICLR) is a global provider of outsourced clinical research services to the pharmaceutical, biotechnology, and medical device industries. The company specializes in conducting clinical trials, data management, and regulatory consulting, helping clients streamline the development and approval of new healthcare products. Established in Ireland, ICON has a broad international presence and is known for its expertise in efficient trial management and innovative solutions in the life sciences sector.
Company News
The global clinical trials market is projected to grow from $127.16 billion in 2025 to $176.32 billion by 2030, with a CAGR of 6.8%. Growth is driven by AI-enabled trial design, decentralized and virtual trials, precision medicine, and real-world evidence studies. North America leads the market while Asia-Pacific is the fastest-growing region. St...
Moore Law PLLC is investigating ICON plc (NASDAQ: ICLC) following the company's announcement of an internal audit committee investigation into accounting practices and controls initiated in October 2025. ICON's stock price dropped significantly on February 12, 2026, when the company disclosed the investigation and delayed its earnings release to ...
Icon Public (ICLR), a clinical research organization, surged nearly 11% on Wednesday after delivering first-quarter 2026 results that beat analyst expectations. While revenue grew modestly by 0.9% to $2 billion and net income fell 27%, the company's gross bookings jumped 22% year-over-year to $3.3 billion, signaling strong demand for its services...
The global decentralized clinical trials market is projected to grow from USD 9.9 billion in 2025 to USD 38.3 billion by 2035, at a CAGR of 14.5%. Growth is driven by digital health technologies, remote patient engagement, and ecosystem expansion involving CROs and platform vendors. Oncology represents the largest therapeutic segment at 45% marke...
The clinical trial data visualization market is projected to grow from $0.89 billion in 2025 to $1.82 billion by 2030 at a CAGR of 15.4%, driven by increasing adoption of AI-powered solutions, cloud-based platforms, and decentralized trials. Major players include ICON plc, Oracle Corporation, and IQVIA Inc., with Asia-Pacific emerging as the fast...
